PMC:7546122 / 1420-1619 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7546122","sourcedb":"PMC","sourceid":"7546122","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7546122","text":"An even higher number of convalescent plasma donors is needed to result in neutralizing antibody (nAb) levels high enough for the resulting IVIG to afford protection against the new infectious agent.","tracks":[{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T9","span":{"begin":38,"end":44},"obj":"Body_part"},{"id":"T10","span":{"begin":88,"end":96},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma62871"},{"subj":"T9","pred":"source","obj":"LitCovid-PD-FMA-UBERON"},{"subj":"T10","pred":"source","obj":"LitCovid-PD-FMA-UBERON"}]},{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T7","span":{"begin":182,"end":192},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"subj":"T7","pred":"source","obj":"LitCovid-PD-MONDO"}]},{"project":"LitCovid-PD-CLO","denotations":[{"id":"T13","span":{"begin":38,"end":44},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"attributes":[{"subj":"T13","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T11","span":{"begin":0,"end":199},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T11","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-FMA-UBERON","color":"#93ecd1","default":true},{"id":"LitCovid-PD-MONDO","color":"#ecb793"},{"id":"LitCovid-PD-CLO","color":"#9d93ec"},{"id":"LitCovid-sentences","color":"#a2ec93"}]}]}}